RxDoctor Payments DataLook up a doctor →

Preetesh Jain, PhD

Internal Medicine · Houston, TXNPI 1578981221

Payments from drug & device makers

$19,469,775in general payments, 2019–2025

Across 789 payments — averaging $24,677 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$10.5M
  • Beigene, Ltd.$6.6M
  • Lilly USA, LLC$1.3M
  • Eli Lilly$780K
  • Beigene AUS Pty Ltd$295K
  • Beone Medicines Ltd.$79K
  • plus $14K from 8 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$19,469,775 in reported general payments places this provider in the 95th percentile of 7,675 internal medicine providers in Texas.

See all internal medicine providers in Texas

Medicare billing

Part B allowed, 2024
$107,760
Medicare patients
275
Services billed
998

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →